Table 1.
Demographic characteristics of the patients
| Hemodialysis | Peritoneal dialysis | Control | ||||
|---|---|---|---|---|---|---|
| PPD ( +) n: 14 |
PPD (−) n: 16 |
PPD ( +) n: 15 |
PPD (−) n: 15 |
PPD ( +) n: 21 |
PPD (−) n: 9 |
|
| Age (years) | 33.9 ± 12.0 | 34.1 ± 11.8 | 35.4 ± 13.9 | 33.5 ± 13.4 | 31.2 ± 12.6 | 33.6 ± 10.9 |
| Sex (male/female) | 9/8 | 7/6 | 10/7 | 7/6 | 8/7 | 7/8 |
| BMI (kg/m2) | 22.1 ± 3.2 | 21.2 ± 2.4 | 23.0 ± 3.0 | 23.2 ± 3.4 | 24.0 ± 2.3 | 23.1 ± 2.9 |
| TSD (months) | 30.8 ± 13.8 | 28.6 ± 14.2 | 27.0 ± 12.7 | 28.1 ± 13.7 | – | – |
| Epo (UI/W) | 4386 ± 3272 | 4272 ± 3849 | 3872 ± 3130 | 3780 ± 2964 | – | – |
| Primary etiology of renal failure | ||||||
| Idiopathic | 10 | 9 | ||||
| Hypertension | 5 | 6 | ||||
| GN | 6 | 4 | ||||
| Amyloidosis | 3 | 4 | ||||
| PKD | 2 | 3 | ||||
| ATN | 1 | 2 | ||||
| Pyelonephritis | 3 | 2 | ||||
ATN acute tubular necrosis, PKD polycystic kidney disease, Epo erithropoietin, W week, TSD time spent on dialysis, GN glomerulonephritis